Patent details

EP1292594 Title: QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS

Basic Information

Publication number:
EP1292594
PCT Application Number:
PCT/GB/2001/002424
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019341767
PCT Publication Number:
WO/2001/094341
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
QUINAZOLINE DERIVATIVES FOR THE TREATMENT OF TUMOURS
French Title of Invention:
DERIVES DE LA QUINAZOLINE POUR LE TRAITEMENT DE TUMEURS
German Title of Invention:
CHINAZOLINDERIVATE ZUR BEHANDLUNG VON TUMOREN
SPC Number:

Dates

Filing date:
01/06/2001
Grant date:
01/09/2004
EP Publication Date:
01/09/2004
PCT Publication Date:
13/12/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/03/2003
EP B1 Publication Date:
01/09/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/06/2016
Expiration date:
01/06/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/06/2001
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
FRIEDERICH PIERRE
From:
25/10/2004
Address:
ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
PLE Patrick
Address:
France (FR)

2

Name:
HENNEQUIN Laurent François André
Address:
France (FR)

Priority

1

Priority Number:
00401581
Priority Date:
06/06/2000
Priority Country:
European Patent Office (EPO) (EP)

2

Priority Number:
01400297
Priority Date:
07/02/2001
Priority Country:
European Patent Office (EPO) (EP)

3

Priority Number:
01400565
Priority Date:
05/03/2001
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C07D 413/12;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
26/05/2015
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages